SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media (DJT) is actively trending following news of its definitive all-stock merger with fusion energy firm TAE Technologies, valued at over $6 billion. This significant pivot into the clean energy sector for AI power is sparking intense debate among the community, with many anticipating a major short squeeze while others view it as another speculative "pump" or "grift".

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron (MU) is trending after delivering a blockbuster earnings report and exceptionally strong guidance, significantly surpassing analyst expectations. This performance is largely driven by robust demand for AI-driven memory, with the company indicating High-Bandwidth Memory (HBM) is fully committed through 2026. The community is actively discussing impressive margin expansion, potential new all-time highs, and numerous analyst price target increases, which is bolstering optimism for the broader AI sector.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing notable volatility, driven by a California court ruling challenging its 'Full Self-Driving' marketing claims and the broader market's reaction to economic data. The community remains sharply divided, with bulls anticipating a swift rebound towards new highs based on Elon Musk's long-term vision, while bears highlight regulatory hurdles and valuation concerns. This intense divergence in sentiment continues to fuel active discussion surrounding the company's technology and market trajectory.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a significant surge following an earnings beat that highlighted its strategic positioning to meet the escalating power demands of AI data centers. Community discussions are heavily focused on whether the company's natural gas-powered fuel cell technology presents a compelling immediate solution in this booming sector, drawing comparisons to peers. While some investors remain cautious due to historical performance and past dilution, many view this as a pivotal moment for FCEL to capitalize on the AI infrastructure buildout.

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Athira Pharma Inc

Athira Pharma is trending with strong momentum after announcing an exclusive license for a Phase 3 breast cancer drug candidate and securing substantial new financing from institutional investors. This strategic pivot into oncology, combined with the stock's relatively low float, is driving community discussions focused on significant upside potential and a possible short squeeze.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending due to recent confirmation from the U.S. Department of Transportation that its Santa Ynez Unit pipeline is an interstate facility, shifting regulatory authority to federal oversight. This development has ignited strong bullish sentiment within the community, with many anticipating substantial upside and a potential short squeeze as operational hurdles may diminish. Nevertheless, some market participants remain wary of the company's financial structure and ongoing challenges with state-level approvals.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as compelling interim real-world evidence for DefenCath demonstrates substantial reductions in catheter-related bloodstream infections, reinforcing its potential as a standard of care. This positive clinical validation is a key talking point among investors, who are also actively discussing the impact of recent CMS decisions on future reimbursement and the influence of market dynamics, including significant short interest and strategic institutional accumulation, on the stock's price action.

Mega Fortune Co., Ltd. operates as an investment holding company. It specializes in delivering comprehensive IoT solutions and services across various industries. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

MGRT is experiencing extreme volatility and trading halts, driven by its status as a recent, low-float Hong Kong IPO. The community is sharply divided, with many speculating on it as a pump and dump scheme while others chase quick profits, aligning it with a trend of highly speculative Asian offerings.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog Crypto ($DOG) is trending with strong community conviction fueled by major accumulation from entities like C2 Blockchain, which is significantly expanding its $DOG treasury. The "DOG Army" is actively discussing its position as the leading Bitcoin-native memecoin, highlighting its fixed supply on the Runes protocol and its potential to onboard new users to Bitcoin while challenging other legacy meme coins. Despite market fluctuations, holders remain bullish, viewing current price action as prime opportunities for further accumulation.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is currently trending amid widespread anticipation of an imminent Executive Order to reclassify cannabis to Schedule III, a move seen by many as a monumental shift for the entire sector. The community is buzzing with speculation about a potential short squeeze, significant institutional investment, and the elimination of 280E tax burdens, while some express caution about a 'sell the news' event or the direct impact on Canadian operators. This potential regulatory change is widely viewed as a foundational step to unlock new opportunities and reshape the cannabis market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gregg Williams Acquires 1,737,765 Shares of Vivani Medical (NASDAQ:VANI) Stock

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 1,737,765 shares of Vivani Medical stock in a transaction that occurred on Monday, December 15th. The shares were...

FY2025 EPS Estimates for Vivani Medical Boosted by Analyst

Vivani Medical, Inc. (NASDAQ:VANI - Free Report) - Investment analysts at HC Wainwright upped their FY2025 earnings per share estimates for shares of Vivani Medical in a research report issued on...

Vivani Medical (NASDAQ:VANI) Upgraded to "Sell" at Wall Street Zen

Wall Street Zen raised Vivani Medical to a "sell" rating in a research report on Saturday...

Gregg Williams Purchases 1,737,764 Shares of Vivani Medical (NASDAQ:VANI) Stock

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,737,764 shares of Vivani Medical stock in a transaction on Saturday, November 15th. The stock was purchased at...

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Acquires 1,737,764 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 1,737,764 shares of Vivani Medical stock in a transaction dated Saturday, November 15th. The shares were bought...

Vivani Medical (NASDAQ:VANI) Upgraded to Hold at Zacks Research

Zacks Research raised shares of Vivani Medical from a "strong sell" rating to a "hold" rating in a report on Wednesday...

Vivani Medical (NASDAQ:VANI) Issues Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.11) EPS for the quarter, beating analysts' consensus estimates of ($0.12...

Vivani Medical (VANI) Projected to Post Earnings on Wednesday

Vivani Medical (NASDAQ:VANI) will be releasing its Q3 2025 earnings before the market opens on Wednesday, November 12. (View Earnings Report at...

Vivani Medical, Inc. (VANI), on Wednesday, <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.vivani.com/investors/news-events/press-releases/detail/188/vivani-medical-announces-positive-preclinical-weight-loss">announced</a> promising preclinical data for its semaglutide implant in development for weight management in overweight patients.NPM-139 is a small, subdermal semaglutide implant. Semaglutide is the active ingredient in popular weight-loss drugs such as Ozempic or Wegovy.Vivani Medical CEO Adam Mendelsohn said products containing semaglutide generated $25 billion in 2024, and demand for these products continues to soar.“Since over half of these patients regularly miss doses as indicated by real-world medication adherence data, we believe that there is a tremendous opportunity for a more convenient delivery option that will eliminate missed doses and thereby improve real-world health outcomes,” he said.The company said on Wednesday that a single administration of the implant in healthy rats resulted in 20% lower body weight through a 91-day treatment period as compared to a control group that received a sham implant.NPM-139 is being initially developed as a twice-yearly implant but has the potential benefit of once-yearly administration, the company said.The company also said it recently successfully implanted an initial group of human subjects with NPM-115, a miniature, ultra long-acting exenatide implant aimed at overweight persons.Data from the study of NPM-115 is expected to be available mid-2025. The study is also expected to pave the way for the development of NPM-139, the company said.On Stocktwits, retail sentiment about Vivani rose from ‘bullish’ to ‘extremely bullish’ territory while message volume jumped from ‘low’ to ‘high’ in the past 24 hours.<figure class="image"><img style="aspect-ratio:649/150;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_26_at_1_56_56_PM_png_deb5769989.webp" alt="VANI's Sentiment Meter and Message Volume as of 1:55 p.m. ET on March 26, 2025 | Source: Stocktwits" width="649" height="150"><figcaption>VANI's Sentiment Meter and Message Volume as of 1:55 p.m. ET on March 26, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits commended the company’s idea of implants, taking out the need for daily pills or injections.<stembedurl>https://stocktwits.com/ZabDad/message/609254484</stembedurl>Brokerage H.C. Wainwright said on Wednesday that the preclinical data validates the versatility of the company’s proprietary NanoPortal implant technology while reiterating a ‘Buy’ rating on the shares with a price target of $4.A Stocktwits user, however, highlighted the company’s low cash. As of Sept. 30, 2024, Vivani had cash, cash equivalents, and restricted cash totaling $21 million.<stembedurl>https://stocktwits.com/Earl40/message/609298832</stembedurl><a href="https://stocktwits.com/symbol/VANI">VANI shares</a> traded nearly 2% higher on Wednesday afternoon. The stock is down over 6% this year and by over 40% in the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-spins-off-micromobility-business-into-new-company-also/chJbT8iRb3m">Rivian Spins Off Micromobility Business Into New Company ‘Also’: Retail’s Elated</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A tape measure lies on a scale while a young woman buries her head in her hands in the background. (Photo by Pia Bayer/picture alliance via Getty Images)

Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars

The company said on Wednesday that a single administration of the implant in healthy rats resulted in 20% lower body weight through a 91-day treatment period as compared to a control group that received a sham implant. 

Equity

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Vivani Medical Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

VANI
Vivani Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VANI News

VANIVivani Medical Inc